Top Key Companies for Adult Stem Cells Market: Neurogeneration, Neuralstem, Beike Biotechnology Co. Ltd., Capricor Inc., Mesoblast Ltd., Celyad, Gamida Cell Ltd., Juventas Therapeutics Inc., Brainstorm Cell Therapeutics Inc., Cellular Dynamics International, Epistem Ltd., Cytori Therapeutics Inc., International Stem Cell Corp., Hybrid Organ Gmbh, Globalstem, Cellerix Sa, Biotime Inc., Clontech, Caladrius Biosciences Inc., Intellicell Biosciences Inc., Cellerant Therapeutics Inc..
Global Adult Stem Cells Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Adult Stem Cells Market Overview And Scope:
The Global Adult Stem Cells Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Adult Stem Cells utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Global Adult Stem Cells Market Segmentation
By Type, Adult Stem Cells market has been segmented into:
Epithelial Stem Cells
Hematopoietic Stem Cells
By Application, Adult Stem Cells market has been segmented into:
Neurodegenerative Diseases
Heart Diseases
Bone Diseases
Others
Regional Analysis of Adult Stem Cells Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Adult Stem Cells Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Adult Stem Cells market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Adult Stem Cells market.
Top Key Companies Covered in Adult Stem Cells market are:
Neurogeneration
Neuralstem
Beike Biotechnology Co. Ltd.
Capricor Inc.
Mesoblast Ltd.
Celyad
Gamida Cell Ltd.
Juventas Therapeutics Inc.
Brainstorm Cell Therapeutics Inc.
Cellular Dynamics International
Epistem Ltd.
Cytori Therapeutics Inc.
International Stem Cell Corp.
Hybrid Organ Gmbh
Globalstem
Cellerix Sa
Biotime Inc.
Clontech
Caladrius Biosciences Inc.
Intellicell Biosciences Inc.
Cellerant Therapeutics Inc.
Key Questions answered in the Adult Stem Cells Market Report:
1. What is the expected Adult Stem Cells Market size during the forecast period, 2025-2032?
2. Which region is the largest market for the Adult Stem Cells Market?
3. What is the expected future scenario and the revenue generated by different regions and countries in the Adult Stem Cells Market, such as North America, Europe, AsiaPacific & Japan, China, U.K., South America, and Middle East and Africa?
4. What is the competitive strength of the key players in the Adult Stem Cells Market on the basis of the analysis of their recent developments, product offerings, and regional presence?
5. Where do the key Adult Stem Cells companies lie in their competitive benchmarking compared to the factors of market coverage and market potential?
6. How are the adoption scenario, related opportunities, and challenges impacting the Adult Stem Cells Markets?
7. How is the funding and investment landscape in the Adult Stem Cells Market?
8. Which are the leading consortiums and associations in the Adult Stem Cells Market, and what is their role in the market?
Research Methodology for Adult Stem Cells Market Report:
The report presents a detailed assessment of the Adult Stem Cells Market, along with qualitative inputs and insights from Company. This research study involved the extensive use of both primary and secondary sources.Various factors affecting the industry were studied to identify the segmentation types; industry trends; key players; competitive landscape of different products and services provided by separate market players;key market dynamics, such as drivers, restraints, opportunities, challenges, and industry trends; and key player strategies. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights.Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Adult Stem Cells Market by Type
5.1 Adult Stem Cells Market Overview Snapshot and Growth Engine
5.2 Adult Stem Cells Market Overview
5.3 Epithelial Stem Cells
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Epithelial Stem Cells: Geographic Segmentation
5.4 Hematopoietic Stem Cells
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Hematopoietic Stem Cells: Geographic Segmentation
Chapter 6: Adult Stem Cells Market by Application
6.1 Adult Stem Cells Market Overview Snapshot and Growth Engine
6.2 Adult Stem Cells Market Overview
6.3 Neurodegenerative Diseases
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Neurodegenerative Diseases: Geographic Segmentation
6.4 Heart Diseases
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Heart Diseases: Geographic Segmentation
6.5 Bone Diseases
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Bone Diseases: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Adult Stem Cells Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Adult Stem Cells Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Adult Stem Cells Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 NEUROGENERATION
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 NEURALSTEM
7.4 BEIKE BIOTECHNOLOGY CO. LTD.
7.5 CAPRICOR INC.
7.6 MESOBLAST LTD.
7.7 CELYAD
7.8 GAMIDA CELL LTD.
7.9 JUVENTAS THERAPEUTICS INC.
7.10 BRAINSTORM CELL THERAPEUTICS INC.
7.11 CELLULAR DYNAMICS INTERNATIONAL
7.12 EPISTEM LTD.
7.13 CYTORI THERAPEUTICS INC.
7.14 INTERNATIONAL STEM CELL CORP.
7.15 HYBRID ORGAN GMBH
7.16 GLOBALSTEM
7.17 CELLERIX SA
7.18 BIOTIME INC.
7.19 CLONTECH
7.20 CALADRIUS BIOSCIENCES INC.
7.21 INTELLICELL BIOSCIENCES INC.
7.22 CELLERANT THERAPEUTICS INC.
Chapter 8: Global Adult Stem Cells Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Epithelial Stem Cells
8.2.2 Hematopoietic Stem Cells
8.3 Historic and Forecasted Market Size By Application
8.3.1 Neurodegenerative Diseases
8.3.2 Heart Diseases
8.3.3 Bone Diseases
8.3.4 Others
Chapter 9: North America Adult Stem Cells Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Epithelial Stem Cells
9.4.2 Hematopoietic Stem Cells
9.5 Historic and Forecasted Market Size By Application
9.5.1 Neurodegenerative Diseases
9.5.2 Heart Diseases
9.5.3 Bone Diseases
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Adult Stem Cells Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Epithelial Stem Cells
10.4.2 Hematopoietic Stem Cells
10.5 Historic and Forecasted Market Size By Application
10.5.1 Neurodegenerative Diseases
10.5.2 Heart Diseases
10.5.3 Bone Diseases
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Adult Stem Cells Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Epithelial Stem Cells
11.4.2 Hematopoietic Stem Cells
11.5 Historic and Forecasted Market Size By Application
11.5.1 Neurodegenerative Diseases
11.5.2 Heart Diseases
11.5.3 Bone Diseases
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Adult Stem Cells Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Epithelial Stem Cells
12.4.2 Hematopoietic Stem Cells
12.5 Historic and Forecasted Market Size By Application
12.5.1 Neurodegenerative Diseases
12.5.2 Heart Diseases
12.5.3 Bone Diseases
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Adult Stem Cells Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Epithelial Stem Cells
13.4.2 Hematopoietic Stem Cells
13.5 Historic and Forecasted Market Size By Application
13.5.1 Neurodegenerative Diseases
13.5.2 Heart Diseases
13.5.3 Bone Diseases
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Adult Stem Cells Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Epithelial Stem Cells
14.4.2 Hematopoietic Stem Cells
14.5 Historic and Forecasted Market Size By Application
14.5.1 Neurodegenerative Diseases
14.5.2 Heart Diseases
14.5.3 Bone Diseases
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Adult Stem Cells Scope:
|
Report Data
|
Adult Stem Cells Market
|
|
Adult Stem Cells Market Size in 2025
|
USD XX million
|
|
Adult Stem Cells CAGR 2025 - 2032
|
XX%
|
|
Adult Stem Cells Base Year
|
2024
|
|
Adult Stem Cells Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Neurogeneration, Neuralstem, Beike Biotechnology Co. Ltd., Capricor Inc., Mesoblast Ltd., Celyad, Gamida Cell Ltd., Juventas Therapeutics Inc., Brainstorm Cell Therapeutics Inc., Cellular Dynamics International, Epistem Ltd., Cytori Therapeutics Inc., International Stem Cell Corp., Hybrid Organ Gmbh, Globalstem, Cellerix Sa, Biotime Inc., Clontech, Caladrius Biosciences Inc., Intellicell Biosciences Inc., Cellerant Therapeutics Inc..
|
|
Key Segments
|
By Type
Epithelial Stem Cells Hematopoietic Stem Cells
By Applications
Neurodegenerative Diseases Heart Diseases Bone Diseases Others
|